{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:37:01Z","timestamp":1792892221018,"version":"4.5.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.arr.2025.102736","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T19:49:48Z","timestamp":1742672988000},"page":"102736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Advanced biomarkers: Beyond amyloid and tau: Emerging non-traditional biomarkers for alzheimer`s diagnosis and progression"],"prefix":"10.1016","volume":"108","author":[{"given":"Meher Rijwana","family":"Afrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj Ghritakousik","family":"Upadhyaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-1504","authenticated-orcid":false,"given":"Kunal","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nongmaithem Randhoni","family":"Chanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibyajyoti","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pukar","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyendra","family":"Deka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2025.102736_bib1","doi-asserted-by":"crossref","first-page":"1231486","DOI":"10.3389\/fgene.2023.1231486","article-title":"A new perspective on Alzheimer\u2019s disease: microRNAs and circular RNAs","volume":"14","author":"Abidin","year":"2023","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/scd.12342","article-title":"Evaluation of salivary acetylcholinesterase and pseudocholinesterase in patients with Alzheimer\u2019s disease: A case\u2013control study","volume":"39","author":"Ahmadi-Motamayel","year":"2019","journal-title":"Spec. Care Dent."},{"issue":"20","key":"10.1016\/j.arr.2025.102736_bib3","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1523\/JNEUROSCI.2920-18.2019","article-title":"Synaptopodin deficiency ameliorates symptoms in the 3xTg mouse model of alzheimer\u2019s disease","volume":"39","author":"Aloni","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2025.102736_bib4","unstructured":"Alzheimers Rates by Country. (2019). World Population Review. \u3008https:\/\/worldpopulationreview.com\/country-rankings\/alzheimers-rates-by-country\u3009."},{"key":"10.1016\/j.arr.2025.102736_bib5","author":"Apostolova","year":"2015","journal-title":"Brain amyloidosis ascertainment Cogn., Imaging, Peripher. blood Protein Meas."},{"key":"10.1016\/j.arr.2025.102736_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2015.00236","article-title":"Blood-based proteomic biomarkers of Alzheimer\u2019s disease pathology","volume":"6","author":"Baird","year":"2015","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib7","first-page":"ZC58","article-title":"Can salivary acetylcholinesterase be a diagnostic biomarker for Alzheimer?","volume":"11","author":"Bakhtiari","year":"2017","journal-title":"J. Clin. Diagn. Res.: JDCR"},{"issue":"11","key":"10.1016\/j.arr.2025.102736_bib8","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200861","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease","volume":"217","author":"Barth\u00e9lemy","year":"2020","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.arr.2025.102736_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1023\/B:JOBB.0000041772.74810.92","article-title":"Mitochondrial dysfunction and oxidative damage in Alzheimer\u2019s and Parkinson\u2019s diseases and coenzyme Q 10 as a potential treatment","volume":"36","author":"Beal","year":"2004","journal-title":"J. Bioenerg. Biomembr."},{"issue":"12","key":"10.1016\/j.arr.2025.102736_bib10","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1093\/brain\/awaa342","article-title":"Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer\u2019s disease","volume":"143","author":"Benedet","year":"2020","journal-title":"Brain: A J. Neurol."},{"issue":"12","key":"10.1016\/j.arr.2025.102736_bib11","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels across the Alzheimer Disease Continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.arr.2025.102736_bib12","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/alz.12745","article-title":"Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer\u2019s disease diagnosis within 17 years","volume":"19","author":"Beyer","year":"2023","journal-title":"Alzheimer\u2019S. Dement.: J. Alzheimer\u2019S. Assoc."},{"issue":"6","key":"10.1016\/j.arr.2025.102736_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.arr.2025.102736_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gps.1882","article-title":"Developing a simple laboratory test for Alzheimer\u2019s disease: Measuring acetylcholinesterase in saliva - A pilot study","volume":"23","author":"Boston","year":"2008","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"9","key":"10.1016\/j.arr.2025.102736_bib15","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol."},{"issue":"May","key":"10.1016\/j.arr.2025.102736_bib16","first-page":"131","article-title":"Early diagnosis of mild cognitive impairment and Alzheimer\u2019s disease based on salivary lactoferrin","volume":"8","author":"Carro","year":"2017","journal-title":"Alzheimer\u2019S. Dement.: Diagn., Assess. Dis. Monit."},{"issue":"9","key":"10.1016\/j.arr.2025.102736_bib17","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1084\/jem.20180484","article-title":"TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer\u2019s disease","volume":"215","author":"Chakrabarty","year":"2018","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-023-00595-7","article-title":"The gut microbiome in Alzheimer\u2019s disease: what we know and what remains to be explored","volume":"18","author":"Chandra","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12035-023-03578-3","article-title":"Non-invasive Biomarkers for Early Detection of Alzheimer\u2019s Disease. a New-Age Perspective","volume":"61","author":"Chimthanawala","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib20","article-title":"Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimer\u2019S. Res. Ther."},{"issue":"9","key":"10.1016\/j.arr.2025.102736_bib21","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1111\/ejn.15619","article-title":"Diabetes: Risk factor and translational therapeutic implications for Alzheimer\u2019s disease","volume":"56","author":"Cummings","year":"2022","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.arr.2025.102736_bib22","article-title":"Resting-state fMRI as a biomarker for Alzheimer\u2019s disease","volume":"4","author":"Damoiseaux","year":"2012","journal-title":"Alzheimer\u2019S. Res. Ther."},{"issue":"4","key":"10.1016\/j.arr.2025.102736_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/neur.1996.0056","article-title":"Structural correlates of cognition in dementia: Quantification and assessment of synapse change","volume":"5","author":"DeKosky","year":"1996","journal-title":"Neurodegener.: A J. Neurodegener. Disord., Neuroprotection Neuroregeneration"},{"issue":"24","key":"10.1016\/j.arr.2025.102736_bib24","doi-asserted-by":"crossref","first-page":"13693","DOI":"10.1021\/acsami.5b03619","article-title":"Hybrid Graphene Oxide Based Plasmonic-Magnetic Multifunctional Nanoplatform for Selective Separation and Label-Free Identification of Alzheimer\u2019s Disease Biomarkers","volume":"7","author":"Demeritte","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"20","key":"10.1016\/j.arr.2025.102736_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms252010911","article-title":"Blood-Based Biomarkers in Alzheimer\u2019s Disease: Advancing Non-Invasive Diagnostics and Prognostics","volume":"25","author":"Dhauria","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102736_bib26","first-page":"484","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021"},{"key":"10.1016\/j.arr.2025.102736_bib27","article-title":"Biomarkers in Alzheimer\u2019s disease: role in early and differential diagnosis and recognition of atypical variants","volume":"15","author":"Dubois","year":"2023"},{"issue":"7","key":"10.1016\/j.arr.2025.102736_bib28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s43587-022-00251-7","article-title":"Reducing decoys focuses fighting microglia","volume":"2","author":"Duggan","year":"2022","journal-title":"Nat. Aging"},{"issue":"4","key":"10.1016\/j.arr.2025.102736_bib29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jalz.2019.09.004","article-title":"Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer\u2019s disease","volume":"16","author":"Elahi","year":"2020","journal-title":"Alzheimer\u2019S. Dement."},{"issue":"2","key":"10.1016\/j.arr.2025.102736_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bj.2018.03.004","article-title":"Salivary biomarkers for the diagnosis and monitoring of neurological diseases","volume":"41","author":"Farah","year":"2018","journal-title":"Biomed. J."},{"issue":"6","key":"10.1016\/j.arr.2025.102736_bib31","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","article-title":"Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study","volume":"11","author":"Fiandaca","year":"2015","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.arr.2025.102736_bib32","first-page":"730","article-title":"The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer\u2019s disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta-analysis","volume":"11","author":"Forgrave","year":"2019"},{"issue":"10","key":"10.1016\/j.arr.2025.102736_bib33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1006\/cyto.1997.0232","article-title":"Beta-amyloid fragment potentiates IL-6 and TNF-alpha secretion by LPS in astrocytes but not in microglia","volume":"9","author":"Forloni","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.arr.2025.102736_bib34","unstructured":"From The Dementia Research Centre, ( P S J W. (2017). Serum neurofilament light in familial Alzheimer disease A marker of early neurodegeneration."},{"issue":"8","key":"10.1016\/j.arr.2025.102736_bib35","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","article-title":"Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in Subjective Cognitive Decline and Mild Cognitive Impairment","volume":"269","author":"Giacomucci","year":"2022","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/WNL.0000000000001702","article-title":"Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease","volume":"85","author":"Goetzl","year":"2015","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.arr.2025.102736_bib37","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1096\/fj.201600816R","article-title":"Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer\u2019s disease","volume":"30","author":"Goetzl","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2025.102736_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102834","article-title":"Decreased salivary lactoferrin levels are specific to Alzheimer\u2019s disease","volume":"57","author":"Gonz\u00e1lez-S\u00e1nchez","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2025.102736_bib39","article-title":"Deregulated mitochondrial microRNAs in Alzheimer\u2019s disease: Focus on synapse and mitochondria","volume":"73","author":"Gowda","year":"2022"},{"key":"10.1016\/j.arr.2025.102736_bib40","first-page":"222","article-title":"New insights into atypical Alzheimer\u2019s disease in the era of biomarkers","volume":"20","author":"Graff-Radford","year":"2021"},{"key":"10.1016\/j.arr.2025.102736_bib41","series-title":"Association of Early-Onset Alzheimer\u2019s Disease with an Interleukin-1 Gene Polymorphism","author":"Grimaldi","year":"2000"},{"issue":"6","key":"10.1016\/j.arr.2025.102736_bib42","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000107700","article-title":"Peripheral inflammatory cytokines as biomarkers in Alzheimer\u2019s disease and mild cognitive impairment","volume":"4","author":"Guerreiro","year":"2007","journal-title":"Neurodegener. Dis."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15616\/BSL.2015.21.1.1","article-title":"MicroRNAs as Novel Biomarkers for the Diagnosis of Alzheimer\u2019s Disease and Modern Advancements in the Treatment","volume":"21","author":"Gunasekaran","year":"2015","journal-title":"Biomed. Sci. Lett."},{"issue":"s1","key":"10.1016\/j.arr.2025.102736_bib44","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.3233\/JAD-201059","article-title":"New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer\u2019s Disease","volume":"82","author":"Guzman-Martinez","year":"2021","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12242-1","article-title":"Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer\u2019s disease","volume":"10","author":"Hadoux","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.arr.2025.102736_bib46","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3233\/JAD-160206","article-title":"Sensing of Alzheimer\u2019s Disease and Multiple Sclerosis Using Nano-Bio Interfaces","volume":"59","author":"Hajipour","year":"2017","journal-title":"J. Alzheimer\u2019S. Dis.: JAD"},{"issue":"9","key":"10.1016\/j.arr.2025.102736_bib47","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","article-title":"Developing the ATX(N) classification for use across the Alzheimer disease continuum","volume":"17","author":"Hampel","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.arr.2025.102736_bib48","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer\u2019s disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat. Aging"},{"issue":"9","key":"10.1016\/j.arr.2025.102736_bib49","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209884","article-title":"Challenges in a Biological Definition of Alzheimer Disease","volume":"103","author":"Hazan","year":"2024","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-21131-4","article-title":"Saliva as a medium to detect and measure biomarkers related to pain","volume":"8","author":"Jasim","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.arr.2025.102736_bib51","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/s41591-023-02476-4","article-title":"Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer\u2019s disease","volume":"29","author":"Johnson","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2025.102736_bib52","article-title":"Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: Breaking the memory barrier","volume":"101","author":"Kamatham","year":"2024"},{"issue":"11","key":"10.1016\/j.arr.2025.102736_bib53","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/clinchem\/hvad139","article-title":"Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology","volume":"69","author":"Kang","year":"2023","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.arr.2025.102736_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21041505","article-title":"Lipids and Alzheimer \u2019 s Disease","volume":"21","author":"Kao","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.arr.2025.102736_bib55","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaneurol.2015.1867","article-title":"Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic Alzheimer disease","volume":"72","author":"Kester","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.102736_bib56","first-page":"577","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018"},{"key":"10.1016\/j.arr.2025.102736_bib57","first-page":"575","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018"},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/WNO.0b013e318267fd5f","article-title":"Retinal nerve fiber layer thickness in patients with Alzheimer disease","volume":"33","author":"Kirbas","year":"2013","journal-title":"J. Neuro-Ophthalmol.: Off. J. North Am. Neuro-Ophthalmol. Soc."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-022-00296-z","article-title":"Advances in the development of new biomarkers for Alzheimer\u2019s disease","volume":"11","author":"Klyucherev","year":"2022","journal-title":"Transl. Neurodegener."},{"issue":"4","key":"10.1016\/j.arr.2025.102736_bib60","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1021\/cn3002015","article-title":"Glyconanoparticle aided detection of \u03b2-amyloid by magnetic resonance imaging and attenuation of \u03b2-amyloid induced cytotoxicity","volume":"4","author":"Kouyoumdjian","year":"2013","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib61","doi-asserted-by":"crossref","first-page":"21745","DOI":"10.1038\/s41598-020-78031-9","article-title":"Urinary metabolic phenotyping for Alzheimer\u2019s disease","volume":"10","author":"Kurbatova","year":"2020","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.arr.2025.102736_bib62","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jalz.2014.10.009","article-title":"Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer\u2019s disease","volume":"11","author":"Kvartsberg","year":"2015","journal-title":"Alzheimer\u2019S. Dement."},{"issue":"6","key":"10.1016\/j.arr.2025.102736_bib63","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3341\/kjo.2016.0118","article-title":"Analysis of the Retinal Nerve Fiber Layer Thickness in Alzheimer Disease and Mild Cognitive Impairment","volume":"31","author":"Kwon","year":"2017","journal-title":"Korean J. Ophthalmol.: KJO"},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24082-z","article-title":"Identifying individuals with high risk of Alzheimer\u2019s disease using polygenic risk scores","volume":"12","author":"Leonenko","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.arr.2025.102736_bib65","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jalz.2019.07.002","article-title":"Mild cognitive impairment has similar alterations as Alzheimer\u2019s disease in gut microbiota","volume":"15","author":"Li","year":"2019","journal-title":"Alzheimer\u2019S. Dement."},{"issue":"5","key":"10.1016\/j.arr.2025.102736_bib66","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1096\/fj.14-262683","article-title":"Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia","volume":"29","author":"Li","year":"2015","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib67","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12993-024-00265-8","article-title":"Fecal microbiota transplantation attenuates Alzheimer\u2019s disease symptoms in APP\/PS1 transgenic mice via inhibition of the TLR4-MyD88-NF-\u03baB signaling pathway-mediated inflammation","volume":"21","author":"Li","year":"2025","journal-title":"Behav. Brain Funct.: BBF"},{"issue":"15","key":"10.1016\/j.arr.2025.102736_bib68","doi-asserted-by":"crossref","first-page":"15260","DOI":"10.18632\/aging.103356","article-title":"The relationship between urinary Alzheimer-associated neuronal thread protein and blood biochemical indicators in the general population","volume":"12","author":"Li","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.arr.2025.102736_bib69","article-title":"Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer\u2019s Disease","volume":"8","author":"Ling","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.arr.2025.102736_bib70","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","article-title":"Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer\u2019s Disease","volume":"100","author":"Litvinchuk","year":"2018","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.arr.2025.102736_bib71","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1002\/alz.14230","article-title":"Plasma miRNAs across the Alzheimer\u2019s disease continuum: Relationship to central biomarkers","volume":"20","author":"Liu","year":"2024","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.arr.2025.102736_bib72","first-page":"51","article-title":"Tracking the potential involvement of metabolic disease in Alzheimer\u2019s disease\u2014Biomarkers and beyond","volume":"154","author":"Luchsinger","year":"2020"},{"issue":"3","key":"10.1016\/j.arr.2025.102736_bib73","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-160835","article-title":"MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer\u2019s Disease","volume":"55","author":"Lusardi","year":"2017","journal-title":"J. Alzheimer\u2019S. Dis.: JAD"},{"key":"10.1016\/j.arr.2025.102736_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.720167","article-title":"Ophthalmic Biomarkers for Alzheimer\u2019s Disease: A Review","volume":"13","author":"Majeed","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"17","key":"10.1016\/j.arr.2025.102736_bib75","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1021\/jm900631m","article-title":"A novel decoy that interrupts G93A-superoxide dismutase gain of interaction with malate dehydrogenase improves survival in an amyotrophic lateral sclerosis cell model","volume":"52","author":"Mali","year":"2009","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.arr.2025.102736_bib76","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1471-4906(01)01941-X","article-title":"Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines","volume":"22","author":"Mantovani","year":"2001","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.arr.2025.102736_bib77","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","article-title":"Cellular actions of \u03b2-amyloid precursor protein and its soluble and fibrillogenic derivatives","volume":"77","author":"Mattson","year":"1997","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.arr.2025.102736_bib78","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients with Alzheimer Disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"issue":"15","key":"10.1016\/j.arr.2025.102736_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153810","article-title":"Lipid and lipid raft alteration in aging and neurodegenerative diseases: A window for the development of new biomarkers","volume":"20","author":"Mesa-Herrera","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102736_bib80","first-page":"63","article-title":"AD molecular: PET amyloid imaging across the Alzheimer\u2019s disease spectrum: From disease mechanisms to prevention","volume":"165","author":"Meyer","year":"2019"},{"issue":"11","key":"10.1016\/j.arr.2025.102736_bib81","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1002\/alz.14150","article-title":"Considerations for widespread implementation of blood-based biomarkers of Alzheimer\u2019s disease","volume":"20","author":"Mielke","year":"2024","journal-title":"Alzheimer\u2019S. Dement."},{"issue":"18","key":"10.1016\/j.arr.2025.102736_bib82","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in Early Alzheimer\u2019s Disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib83","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/brain\/awaa399","article-title":"Time course of phosphorylated-tau181 in blood across the Alzheimer\u2019s disease spectrum","volume":"144","author":"Moscoso","year":"2021","journal-title":"Brain: A J. Neurol."},{"issue":"6","key":"10.1016\/j.arr.2025.102736_bib84","doi-asserted-by":"crossref","DOI":"10.2174\/1570159X15666170208124324","article-title":"YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer\u2019s Disease","volume":"15","author":"Muszy\u0144ski","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2025.102736_bib85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.irn.2015.05.008","article-title":"Lipidomics of Human Brain Aging and Alzheimer\u2019s Disease Pathology","volume":"122","author":"Naud\u00ed","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.arr.2025.102736_bib86","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018"},{"issue":"9","key":"10.1016\/j.arr.2025.102736_bib87","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1021\/acschemneuro.2c00649","article-title":"Small Molecule Decoys of Aggregation for Elimination of A\u03b2-Peptide Toxicity","volume":"14","author":"Oasa","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"8","key":"10.1016\/j.arr.2025.102736_bib88","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.4103\/1673-5374.389643","article-title":"Small molecular decoys in Alzheimer\u2019s disease","volume":"19","author":"Oasa","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"3","key":"10.1016\/j.arr.2025.102736_bib89","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-231399","article-title":"Small Molecule Decoy of Amyloid-\u03b2 Aggregation Blocks Activation of Microglia-Like Cells","volume":"101","author":"Oasa","year":"2024","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"4","key":"10.1016\/j.arr.2025.102736_bib90","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/156720506778249489","article-title":"Oxidative Stress, Mitochondrial Dysfunction, and Stress Signaling in Alzheimers Disease","volume":"3","author":"Onyango","year":"2006","journal-title":"Curr. Alzheimer Res."},{"issue":"8","key":"10.1016\/j.arr.2025.102736_bib91","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.neurobiolaging.2015.04.011","article-title":"Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer\u2019s disease","volume":"36","author":"Ossenkoppele","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2025.102736_bib92","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.13855","article-title":"Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care","author":"Palmqvist","year":"2024","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.arr.2025.102736_bib93","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1007\/s00415-015-7904-3","article-title":"Dissecting IWG-2 typical and atypical Alzheimer\u2019s disease: insights from cerebrospinal fluid analysis","volume":"262","author":"Paterson","year":"2015","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19862-6","article-title":"Plasma microRNAs as potential biomarkers in early Alzheimer disease expression","volume":"12","author":"Pe\u00f1a-Bautista","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib95","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13195-024-01597-3","article-title":"Elevated A\u03b2 aggregates in feces from Alzheimer\u2019s disease patients: a proof-of-concept study","volume":"16","author":"Pils","year":"2024","journal-title":"Alzheimer\u2019S. Res. Ther."},{"issue":"2","key":"10.1016\/j.arr.2025.102736_bib96","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-2005-7203","article-title":"Differential loss of synaptic proteins in Alzheimer\u2019s disease: Implications for synaptic dysfunction","volume":"7","author":"Reddy","year":"2005","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib97","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10072-006-0562-6","article-title":"Increased intrathecal TGF-\u03b21, but not IL-12, IFN-\u03b3 and IL-10 levels in Alzheimer\u2019s disease patients","volume":"27","author":"Rota","year":"2006","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib98","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3233\/ADR-220081","article-title":"Urinary Cytokines as Potential Biomarkers of Mild Cognitive Impairment and Alzheimer\u2019s Disease: A Pilot Study","volume":"7","author":"Saiyed","year":"2023","journal-title":"J. Alzheimer\u2019S. Dis. Rep."},{"key":"10.1016\/j.arr.2025.102736_bib99","doi-asserted-by":"crossref","unstructured":"Sanyal, P., Mukherjee, S., Das, A., & Sen, A. (2023). Longitudinal Volumetric Study for the Progression of Alzheimer\u2019s Disease from Structural MRI. 2024 IEEE International Conference on Computer Vision and Machine Intelligence, CVMI 2024. https:\/\/doi.org\/10.1109\/CVMI61877.2024.10782874.","DOI":"10.1109\/CVMI61877.2024.10782874"},{"key":"10.1016\/j.arr.2025.102736_bib100","doi-asserted-by":"crossref","unstructured":"Saroja, S.R., Gorbachev, K., Tcw, J., Goate, A.M., & Pereira, A.C. (2022). Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation. https:\/\/doi.org\/10.1073\/pnas.","DOI":"10.1101\/2021.07.07.451493"},{"issue":"9","key":"10.1016\/j.arr.2025.102736_bib101","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.arr.2025.102736_bib102","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.cell.2024.08.049","article-title":"CSF proteomics identifies early changes in autosomal dominant Alzheimer\u2019s disease","volume":"187","author":"Shen","year":"2024","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.arr.2025.102736_bib103","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","article-title":"Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2019s disease","volume":"49","author":"Simard","year":"2006","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.arr.2025.102736_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002266","article-title":"Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study","volume":"14","author":"Snowden","year":"2017","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.arr.2025.102736_bib105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1601-0825.2010.01773.x","article-title":"Saliva: Diagnostics and therapeutic perspectives","volume":"17","author":"Spielmann","year":"2011","journal-title":"Oral. Dis."},{"key":"10.1016\/j.arr.2025.102736_bib106","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1155\/2009\/915041","article-title":"Diffusion tensor imaging in Alzheimer\u2019s disease and mild cognitive impairment","volume":"21","author":"Stebbins","year":"2009","journal-title":"Behav. Neurol."},{"issue":"10","key":"10.1016\/j.arr.2025.102736_bib107","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.0000000000003688","article-title":"Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias","volume":"88","author":"Steinacker","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib108","first-page":"1","article-title":"Amyloid-\u03b2 misfolding as a plasma biomarker indicates risk for future clinical Alzheimer\u2019s disease in individuals with subjective cognitive decline","volume":"12","author":"Stockmann","year":"2020","journal-title":"Alzheimer\u2019S. Res. Ther."},{"issue":"2","key":"10.1016\/j.arr.2025.102736_bib109","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3233\/JAD-151124","article-title":"A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging","volume":"52","author":"Tanifum","year":"2016","journal-title":"J. Alzheimer\u2019S. Dis.: JAD"},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010707","article-title":"Fecal Volatile Organic Compounds and Microbiota Associated with the Progression of Cognitive Impairment in Alzheimer\u2019s Disease","volume":"24","author":"Ubeda","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.arr.2025.102736_bib111","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bbalip.2010.03.007","article-title":"Membrane rafts in Alzheimer\u2019s disease beta-amyloid production","volume":"1801","author":"Vetrivel","year":"2010","journal-title":"Biochim. Et. Biophys. Acta - Mol. Cell Biol. Lipids"},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib112","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nnano.2014.254","article-title":"Towards non-invasive diagnostic imaging of early-stage Alzheimer\u2019s disease","volume":"10","author":"Viola","year":"2015","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00496-7","article-title":"The promise of microRNA-based therapies in Alzheimer\u2019s disease: challenges and perspectives","volume":"16","author":"Walgrave","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2025.102736_bib114","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2019.06.021","article-title":"Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease","volume":"45","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2025.102736_bib115","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease","volume":"3","author":"Wang","year":"2015"},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib116","first-page":"1","article-title":"Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer\u2019s disease: findings based on urine proteomics and machine learning","volume":"15","author":"Wang","year":"2023","journal-title":"Alzheimer\u2019S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102736_bib117","article-title":"Plasma p-tau181 Level Predicts Neurodegeneration and Progression to Alzheimer\u2019s Dementia: A Longitudinal Study","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib118","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000496100","article-title":"Molecular Network Analysis of the Urinary Proteome of Alzheimer\u2019s Disease Patients","volume":"9","author":"Watanabe","year":"2019","journal-title":"Dement. Geriatr. Cogn. Disord. Extra"},{"issue":"3","key":"10.1016\/j.arr.2025.102736_bib119","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000509561","article-title":"Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer\u2019s Disease","volume":"10","author":"Watanabe","year":"2020","journal-title":"Dement. Geriatr. Cogn. Disord. EXTRA"},{"issue":"2","key":"10.1016\/j.arr.2025.102736_bib120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/acn3.518","article-title":"CSF neurogranin or tau distinguish typical and atypical Alzheimer disease","volume":"5","author":"Wellington","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"7","key":"10.1016\/j.arr.2025.102736_bib121","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jalz.2017.01.008","article-title":"Dysregulation of lipids in Alzheimer\u2019s disease and their role as potential biomarkers","volume":"13","author":"Wong","year":"2017","journal-title":"Alzheimer\u2019S. Dement."},{"issue":"3","key":"10.1016\/j.arr.2025.102736_bib122","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3233\/JAD-150619","article-title":"Circulating microRNAs as Biomarkers of Alzheimer\u2019s Disease: A Systematic Review","volume":"49","author":"Wu","year":"2016","journal-title":"J. Alzheimer\u2019S. Dis.: JAD"},{"issue":"1","key":"10.1016\/j.arr.2025.102736_bib123","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13195-020-00627-0","article-title":"Differential blood miRNA expression in brain amyloid imaging-defined Alzheimer\u2019s disease and controls","volume":"12","author":"Wu","year":"2020","journal-title":"Alzheimer\u2019S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102736_bib124","first-page":"761","article-title":"Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls","volume":"17","author":"Yilmaz","year":"2017"},{"issue":"5","key":"10.1016\/j.arr.2025.102736_bib125","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/s41380-022-01476-z","article-title":"Differential expression of MicroRNAs in Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"27","author":"Yoon","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2025.102736_bib126","article-title":"Blood-based molecular biomarkers for Alzheimer\u2019s disease","volume":"12","author":"Zetterberg","year":"2019"},{"issue":"8","key":"10.1016\/j.arr.2025.102736_bib127","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/ckj\/sfae222","article-title":"Decoy receptors as biomarkers for exploring aetiology and designing new therapies","volume":"17","author":"Zoccali","year":"2024","journal-title":"Clin. Kidney J."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725000820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725000820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T09:14:10Z","timestamp":1761642850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163725000820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":127,"alternative-id":["S1568163725000820"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2025.102736","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced biomarkers: Beyond amyloid and tau: Emerging non-traditional biomarkers for alzheimer`s diagnosis and progression","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2025.102736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102736"}}